News

Print

Stephen Sheller was honored with a Lifetime Achievement Award Wednesday, May 20 2015 from American Lawyer Media’s daily newspaper, The Legal Intelligencer. The award was based on his record of verdicts and settlements, service
shire,vyvanse,adderall,whistleblower,stephensheller,qui,tam

American Lawyer Media’s Top Pennsylvania Verdicts and Settlements for 2014 reveals Sheller, P.C. in a familiar spot again in 2014. The firm has been at or near the top of the list for
1099

Are you being misclassified as an “independent contractor” when you really should be considered an employee? Employers are increasingly misclassifying their employees as independent contractors.  This has the effect of denying hard working
The blood pressure drugs Benicar, Benicar HCT, Azor and Tribenzor are the subject of investigations by health care professionals and lawsuits filed by attorneys on behalf of injured patients.

Benicar lawsuits over serious gastrointestinal injury have been consolidated in New Jersey. Contact the attorneys at Sheller, PC at 800-883-2299, via email, or via the inquiry form on this page if you have been
whistleblower

Stephen Sheller appeared on The American Law Journal to discuss why, with historic False Claims Settlements in the billions, are CEOs not going to jail nor are corporations pleading to felony charges? Hosted

ON TV: Stephen A. Sheller appeared on “How is Pharma Faring in the Courts?” on The American Law Journal The American Law Journal on CNN News Philadelphia affiliate WFMZ-TV 2015-04-06  
Screenshot 2015-05-08 10.18.14

Stephen Sheller appeared on the Philadelphia CNN-News affiliate WFMZ-TV program The American Law Journal on “How  Is Pharma Faring in the Courts?”  Host Christopher Naughton welcomed plaintiff’s attorneys Christopher Placitella, Esq. of Cohen Placitella & Roth, Stephen Sheller
top,pa,pennsylvania,verdict,settlement,johnson,johnson,j,and,janssen,risperdal,whistleblower,qui,tam,legal,intelligencer,stephensheller

Sheller, P.C. had the largest settlement in Pennsylvania in 2013-2014 as published in American Lawyer Media’s Legal Intelligencer newspaper. The $2.2 billion settlement with Janssen Pharmaceuticals, a division of Johnson & Johnson, was
Sheller, P.C. attorneys are investigating injuries caused by Bayer and Janssen Pharmaceuticals’ blood thinner drug Xarelto® (Rivaroxaban)

The attorneys of Sheller, P.C. are investigating the serious risks of Xarelto and Pradaxa. The firm offers no cost, no obligation consultations to individuals who have experienced the serious side effect of excessive,
Philadelphia Inquirer page 1 J&J $2.2B Settlement 11_5_13 with annotations better font drop shadow

J&J to pay $2.2B for Improper Promotion of Risperdal BY DAVID SELL WASHINGTON – Health-care giant Johnson & Johnson agreed Monday to plead guilty to a criminal misdemeanor charge and pay $2.2 billion